Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

InterCure (INCR)

(Delayed Data from NSDQ)

$2.66 USD

+0.02 (0.76%)

Updated Apr 26, 2024 03:59 PM ET

After-Market: $2.66 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

Bottom 44% (142 out of 252)

Industry: Medical - Products

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[INCR]

Reports for Purchase

Showing records 21 - 40 ( 45 total )

Industry: Medical Services

Record: 21

05/10/2017

Pages: 11

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 22

03/05/2017

Pages: 29

Healthcare IT, Biopharmaceutical Services and Laboratories: Post-4Q16 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Industry: Medical Services

Record: 23

11/14/2016

Pages: 28

Healthcare: Post 3Q16 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Industry: Medical Services

Record: 24

10/31/2016

Pages: 16

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Industry: Medical Services

Record: 25

10/31/2016

Pages: 6

From Tiny Acorns Mighty Oaks Grow

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 26

08/16/2016

Pages: 11

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 27

08/15/2016

Pages: 28

Healthcare: Post-2Q16 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Industry: Medical Services

Record: 28

07/28/2016

Pages: 3

Initial 2Q16 Conference Call Take-Aways

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 29

05/20/2016

Pages: 14

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Industry: Medical Services

Record: 30

05/19/2016

Pages: 29

Healthcare: Post-1Q16 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Industry: Medical Services

Record: 31

05/02/2016

Pages: 4

Acceleration of Clinical Trial Drives 1Q16 Beat

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 32

05/02/2016

Pages: 5

Is the Margin Expansion Story Over?

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 33

04/18/2016

Industry Report

Pages: 4

Believe It When You See It

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 34

02/25/2016

Pages: 5

The Challenge of High Expectations

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 35

10/30/2015

Pages: 25

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 75.00

Research Provided by a Third Party

Industry: Medical Services

Record: 36

10/30/2015

Pages: 5

Can It Get Better Than This?

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 37

08/03/2015

Pages: 5

A Game of Expectations

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 38

05/15/2015

Pages: 13

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Industry: Medical Services

Record: 39

05/15/2015

Pages: 5

Financial Engineering to Be Accretive, but Share Price Run-Up Remains a Concern

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 40

04/27/2015

Pages: 6

Impressive Margins Sooner than Expected, but Now What?

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party